Literature DB >> 19408064

MRI detection of the cerebellar syndrome in Creutzfeldt-Jakob disease.

Oren S Cohen1, Chen Hoffmann, Hedok Lee, Joab Chapman, Robert K Fulbright, Isak Prohovnik.   

Abstract

Creutzfeldt-Jakob Disease (CJD) is characterized by bilateral basal ganglia hyperintensities on T2W and diffusion-weighted imaging (DWI) magnetic resonance imaging (MRI) scans, consistent with its extrapyramidal neurological manifestations. MRI is diagnostically uninformative about the cerebellar symptoms, equally prominent in CJD. This study was undertaken to explain this apparent paradox. Eleven CJD patients with definite cerebellar or brain stem symptoms were selected from a large prospective study, as well as 11 healthy controls matched for age and gender. All subjects participated in a standardized MRI protocol, including SPGR, fluid-attenuated inversion recovery (FLAIR), DWI and diffusion tensor imaging (DTI). All subjects underwent detailed examination by a neurologist blinded to the radiological findings, who predicted the expected site of cerebral abnormalities. MRI showed good sensitivity for the abnormalities predicted in the cortex (80-90%) and basal ganglia (100%). None of the standard MRI sequences, including DWI, DTI, and FLAIR, revealed any tissue abnormalities in cerebellum or brain stem. Apparent diffusion coefficient (ADC) values, however, were substantially and significantly elevated in several cerebellar structures, where also the volumetric (VBM) analysis revealed elevated cerebrospinal fluid volume, suggesting focal cerebellar atrophy in these CJD patients. In patients with CJD, DWI appears sensitive to the reduced diffusivity in cortex and basal ganglia but insensitive to cerebellar involvement. We propose that the radiological hallmark of cerebellar pathology in CJD is atrophy, revealed quantitatively by both VBM and elevated diffusivity, which is identifiable on ADC maps but poorly visualized in nonquantitative DWI images.

Entities:  

Mesh:

Year:  2009        PMID: 19408064     DOI: 10.1007/s12311-009-0106-8

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  44 in total

1.  Immunohistochemical studies of the PrP(CJD) deposition in Creutzfeldt-Jakob disease.

Authors:  S Tanaka; M Saito; M Morimatsu; E Ohama
Journal:  Neuropathology       Date:  2000-06       Impact factor: 1.906

2.  Initial DWI and ADC imaging may predict outcome in acute disseminated encephalomyelitis: report of two cases of brain stem encephalitis.

Authors:  H Axer; A Ragoschke-Schumm; J Böttcher; C Fitzek; O W Witte; S Isenmann
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-07       Impact factor: 10.154

3.  Diffusion-weighted MRI of haemangioblastomas and other cerebellar tumours.

Authors:  F A Quadery; K Okamoto
Journal:  Neuroradiology       Date:  2003-03-08       Impact factor: 2.804

4.  Prion protein genotype and pathological phenotype studies in sporadic Creutzfeldt-Jakob disease.

Authors:  S T MacDonald; K Sutherland; J W Ironside
Journal:  Neuropathol Appl Neurobiol       Date:  1996-08       Impact factor: 8.090

5.  Subacute spongiform encephalopathy (Creutzfeldt-Jakob disease). The nature and progression of spongiform change.

Authors:  C L Masters; E P Richardson
Journal:  Brain       Date:  1978-06       Impact factor: 13.501

6.  MRI evidence of cerebellar and hippocampal involvement in Creutzfeldt-Jakob disease.

Authors:  M A Poon; S Stuckey; E Storey
Journal:  Neuroradiology       Date:  2001-09       Impact factor: 2.804

7.  Correlation of diffusion-weighted magnetic resonance imaging with neuropathology in Creutzfeldt-Jakob disease.

Authors:  Sanjay Mittal; Peter Farmer; Peter Kalina; Peter B Kingsley; John Halperin
Journal:  Arch Neurol       Date:  2002-01

8.  Distinct neuropsychological characteristics in Creutzfeldt-Jakob disease.

Authors:  J S Snowden; D M A Mann; D Neary
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-12       Impact factor: 10.154

9.  Clinical heterogeneity and unusual presentations of Creutzfeldt-Jakob disease in Jewish patients with the PRNP codon 200 mutation.

Authors:  J Chapman; P Brown; L G Goldfarb; A Arlazoroff; D C Gajdusek; A D Korczyn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-10       Impact factor: 10.154

10.  Sporadic Creutzfeldt-Jakob disease without dementia at onset: clinical features, laboratory tests and sequential diffusion MRI (in an autopsy-proven case).

Authors:  F Pauri; G Amabile; F Fattapposta; A Pierallini; F Bianco
Journal:  Neurol Sci       Date:  2004-10       Impact factor: 3.307

View more
  15 in total

1.  Pruritus in familial Creutzfeldt-Jakob disease: a common symptom associated with central nervous system pathology.

Authors:  Oren S Cohen; Joab Chapman; Hedok Lee; Zeev Nitsan; Shmuel Appel; Chen Hoffman; Hanna Rosenmann; Amos D Korczyn; Isak Prohovnik
Journal:  J Neurol       Date:  2010-08-21       Impact factor: 4.849

2.  Consensus paper: radiological biomarkers of cerebellar diseases.

Authors:  Leonardo Baldarçara; Stuart Currie; M Hadjivassiliou; Nigel Hoggard; Allison Jack; Andrea P Jackowski; Mario Mascalchi; Cecilia Parazzini; Kathrin Reetz; Andrea Righini; Jörg B Schulz; Alessandra Vella; Sara Jane Webb; Christophe Habas
Journal:  Cerebellum       Date:  2015-04       Impact factor: 3.847

3.  Clinical radiological correlation in E200K familial Creutzfeldt-Jakob disease.

Authors:  Oren S Cohen; Joab Chapman; Amos D Korczyn; Oliver L Siaw; Naama Warman-Alaluf; Zeev Nitsan; Shmuel Appel; Esther Kahana; Hanna Rosenmann; Chen Hoffmann
Journal:  J Neural Transm (Vienna)       Date:  2016-09-13       Impact factor: 3.575

4.  Role of magnetic resonance imaging, cerebrospinal fluid, and electroencephalogram in diagnosis of sporadic Creutzfeldt-Jakob disease.

Authors:  Leo H Wang; Robert C Bucelli; Erica Patrick; Dhanashree Rajderkar; Enrique Alvarez Iii; Miranda M Lim; Gabriela Debruin; Victoria Sharma; Sonika Dahiya; Robert E Schmidt; Tammie S Benzinger; Beth A Ward; Beau M Ances
Journal:  J Neurol       Date:  2012-09-12       Impact factor: 4.849

5.  Thalamo-striatal diffusion reductions precede disease onset in prion mutation carriers.

Authors:  Hedok Lee; Hanna Rosenmann; Joab Chapman; Peter B Kingsley; Chen Hoffmann; Oren S Cohen; Esther Kahana; Amos D Korczyn; Isak Prohovnik
Journal:  Brain       Date:  2009-03-24       Impact factor: 13.501

6.  Putaminal volume and diffusion in early familial Creutzfeldt-Jakob disease.

Authors:  Ilana Seror; Hedok Lee; Oren S Cohen; Chen Hoffmann; Isak Prohovnik
Journal:  J Neurol Sci       Date:  2009-10-13       Impact factor: 3.181

7.  Cerebral white matter disruption in Creutzfeldt-Jakob disease.

Authors:  H Lee; O S Cohen; H Rosenmann; C Hoffmann; P B Kingsley; A D Korczyn; J Chapman; I Prohovnik
Journal:  AJNR Am J Neuroradiol       Date:  2012-05-10       Impact factor: 3.825

8.  Unusual presentations in patients with E200K familial Creutzfeldt-Jakob disease.

Authors:  O S Cohen; I Kimiagar; A D Korczyn; Z Nitsan; S Appel; C Hoffmann; H Rosenmann; E Kahana; J Chapman
Journal:  Eur J Neurol       Date:  2016-01-25       Impact factor: 6.089

9.  Selective vulnerability to atrophy in sporadic Creutzfeldt-Jakob disease.

Authors:  Kyan Younes; Julio C Rojas; Amy Wolf; Goh M Sheng-Yang; Matteo Paoletti; Gianina Toller; Eduardo Caverzasi; Maria Luisa Mandelli; Ignacio Illán-Gala; Joel H Kramer; Yann Cobigo; Bruce L Miller; Howard J Rosen; Michael D Geschwind
Journal:  Ann Clin Transl Neurol       Date:  2021-05-05       Impact factor: 4.511

10.  Multiparameter MR imaging in the 6-OPRI variant of inherited prion disease.

Authors:  E De Vita; G R Ridgway; R I Scahill; D Caine; P Rudge; T A Yousry; S Mead; J Collinge; H R Jäger; J S Thornton; H Hyare
Journal:  AJNR Am J Neuroradiol       Date:  2013-03-28       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.